Found: 69
Select item for more details and to access through your institution.
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 5, p. 473, doi. 10.1007/s12185-014-1672-1
- By:
- Publication type:
- Article
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 2, p. 141, doi. 10.1007/s12185-014-1617-8
- By:
- Publication type:
- Article
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 6, p. 749, doi. 10.1007/s12185-013-1346-4
- By:
- Publication type:
- Article
Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 3, p. 382, doi. 10.1007/s12185-013-1270-7
- By:
- Publication type:
- Article
Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 1, p. 92, doi. 10.1007/s12185-012-1237-0
- By:
- Publication type:
- Article
Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia.
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 3, p. 327, doi. 10.1007/s12185-012-1142-6
- By:
- Publication type:
- Article
Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Polymyositis and myocarditis after donor lymphocyte infusion.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Polymorphisms in DNA Repair Genes and MDR1 and the Risk for Non-Hodgkin Lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 6703, doi. 10.3390/ijms15046703
- By:
- Publication type:
- Article
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 62, doi. 10.1111/bjh.12492
- By:
- Publication type:
- Article
Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma.
- Published in:
- Journal of Clinical Apheresis, 2014, v. 29, n. 6, p. 305, doi. 10.1002/jca.21326
- By:
- Publication type:
- Article
The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
- Published in:
- Journal of Clinical Apheresis, 2004, v. 19, n. 3, p. 130, doi. 10.1002/jca.20015
- By:
- Publication type:
- Article
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement.
- Published in:
- Cancer Research & Treatment, 2013, v. 45, n. 2, p. 112, doi. 10.4143/crt.2013.45.2.112
- By:
- Publication type:
- Article
Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0086933
- By:
- Publication type:
- Article
Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0052518
- By:
- Publication type:
- Article
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decreased body mass index is associated with poor prognosis in patients with multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 835, doi. 10.1007/s00277-013-1977-9
- By:
- Publication type:
- Article
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 33, doi. 10.1007/s00277-013-1826-x
- By:
- Publication type:
- Article
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 6, p. 789, doi. 10.1007/s00277-013-1685-5
- By:
- Publication type:
- Article
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 4, p. 471, doi. 10.1007/s00277-012-1640-x
- By:
- Publication type:
- Article
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 2, p. 163, doi. 10.1007/s00277-012-1580-5
- By:
- Publication type:
- Article
A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 7, p. 1023, doi. 10.1007/s00277-012-1420-7
- By:
- Publication type:
- Article
Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 12, p. 1419, doi. 10.1007/s00277-011-1219-y
- By:
- Publication type:
- Article
Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 5, p. 1814, doi. 10.1002/cam4.1450
- By:
- Publication type:
- Article
Patterns of Relapse or Progression After Bortezomib-Based Salvage Therapy in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 2, p. 118, doi. 10.1016/j.clml.2011.11.002
- By:
- Publication type:
- Article
Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 1, p. 62, doi. 10.3816/CLML.2010.n.007
- By:
- Publication type:
- Article
Predictive Efficacy of Interim Positron Emission Tomography/ Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma.
- Published in:
- Chonnam Medical Journal, 2015, v. 51, n. 3, p. 109, doi. 10.4068/cmj.2015.51.3.109
- By:
- Publication type:
- Article
Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic.
- Published in:
- Chonnam Medical Journal, 2015, v. 51, n. 1, p. 1, doi. 10.4068/cmj.2015.51.1.1
- By:
- Publication type:
- Article
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 8, p. 813, doi. 10.1007/s00277-010-0913-5
- By:
- Publication type:
- Article
Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 8, p. 795, doi. 10.1007/s00277-010-0931-3
- By:
- Publication type:
- Article
Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 7, p. 681, doi. 10.1007/s00277-010-0921-5
- By:
- Publication type:
- Article
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 5, p. 475, doi. 10.1007/s00277-009-0856-x
- By:
- Publication type:
- Article
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)
- Published in:
- Annals of Hematology, 2010, v. 89, n. 5, p. 489, doi. 10.1007/s00277-009-0871-y
- By:
- Publication type:
- Article
Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 11, p. 1113, doi. 10.1007/s00277-009-0721-y
- By:
- Publication type:
- Article
Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma.
- Published in:
- Case Reports in Oncology, 2012, v. 5, n. 2, p. 413, doi. 10.1159/000341562
- By:
- Publication type:
- Article
A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment.
- Published in:
- Case Reports in Oncology, 2011, v. 4, n. 1, p. 101, doi. 10.1159/000324920
- By:
- Publication type:
- Article
Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166245
- By:
- Publication type:
- Article
Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 1, p. 44, doi. 10.1002/gcc.22005
- By:
- Publication type:
- Article
Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 774, doi. 10.1002/ajh.23507
- By:
- Publication type:
- Article